Feeds:
Posts
Comments

Search Results for 'Pfizer'

Third Boston Pharmaceutical Symposium on May 3, 2019 at Pfizer, Building 2, Kendall Sq., Cambridge MA.

Posted in Pharmaceutical Analytics on March 26, 2019| Leave a Comment »

Third Boston Pharmaceutical Symposium on May 3, 2019 at Pfizer, Building 2, Kendall Sq., Cambridge MA Reporter: Aviva Lev-Ari, PhD, RN   The Boston Chapter of the American Statistical Association (BCASA) invites you all to attend the Third Boston Pharmaceutical Symposium on May 3, 2019 at Pfizer, Building 2, Kendall Sq., Cambridge MA.   As […]

Read Full Post »

Adam P. Tubman, BSc, MSc, Research Associate 3, Computer Graphics and AI in Drug Discovery – PERSONAL PAGE

Posted in on August 31, 2023|

Adam P. Tubman, BSc, MSc, Research Associate 3, Computer Graphics and AI in Drug Discovery – PERSONAL PAGE https://pharmaceuticalintelligence.com/contributors-biographies/associates/adam-p-tubman-msc-research-associate-3-computer-graphics-and-ai-in-drug-discovery/   HERE, you document your progress every time you logged in work TEMPLATE of the table is in: https://pharmaceuticalintelligence.com/chatgpt-wolfram-plugin/frason-francis-kalapurakal-research-associate-2-personal-page/   Article ID Article Title WordCloud Green = completed Link 301 Health Care Policy Analysis derived from […]

Read Full Post »

Danny Bar-Zohar, MD –  New R&D Leader for new pipelines at Merck KGaA as Luciano Rossetti steps out

Posted in Drug Development Process, drug repurposing, Pharmaceutical Discovery, Pharmaceutical Drug Discovery, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Pharmacogenomics, Scientist: Career considerations on October 15, 2020| Leave a Comment »

Danny Bar-Zohar, MD –  New R&D Leader for new pipelines at Merck KGaA as Luciano Rossetti steps out Reporter: Aviva Lev-Ari, PhD, RN   Danny Bar-Zohar, MD – A Pharmaceutical Executive Profile in R&D: Ex-Novastis, Ex-Teva Experience Partner Company Name Syncona Limited Full-time Dates EmployedApr 2020 – Present Employment Duration7 mos LocationLondon, England, United Kingdom Company […]

Read Full Post »

2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON • IN-PERSON

Posted in Cancer and Current Therapeutics, Cell Biology, Cell Biology, Signaling & Cell Circuits, Cell Processing System in Cell Therapy Process Development, Conference Coverage with Social Media, Gene Regulation, Gene Regulation and Evolution, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology on May 1, 2022| Leave a Comment »

2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON • IN-PERSON Reporter: Aviva Lev-Ari, PhD, RN World Medical Innovation Forum as we bring together global leaders to assess the latest opportunities and challenges, from the investment landscape to key technology developments to manufacturing and regulatory barriers. Gain first-hand insights on medicine’s ultimate game changer. https://worldmedicalinnovation.org/ […]

Read Full Post »

Promises on Covid-19 Vaccines

Posted in COVID-19, Population Health Management, Genetics & Pharmaceutical, Treatment Protocols for COVID-19, Vaccinology, tagged , , , on May 11, 2020| Leave a Comment »

Promises on Covid-19 Vaccines Reporter: Irina Robu, PhD Vaccines play a vital role in keeping us healthy. Currently, scientists are racing through development at speeds never before seen. Even if the stages of vaccine development could be compressed and supplies could be quickly manufactured, it could take months or longer before people can have access […]

Read Full Post »

Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure.

Posted in coronavirus, Coronavirus Gene Expression, COVID-19, COVID-19, Drug Development Process, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, Image Processing/Computing, Infectious Disease Immunodiagnostics, Mechanisms of infection by SARS-CoV-2, Medical Imaging Technology, Mutagenesis, Population Health Management, Proteins, SARS-CoV-2, SARS-CoV-2 circulating variants , SARS-CoV-2 Viral Variants, Uncategorized, Vaccinology, Variation in human protein-coding regions, virology, Virology - Vector-borne DIsease, Virtual Drug Molecule Screening targeting SAR-CoV-2 proteins, tagged , , , , , , , , on April 10, 2021| Leave a Comment »

Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure. Reporter: Dr. Premalata Pati, Ph.D., Postdoc SARS-CoV-2, the virus that causes COVID-19, has had a major impact on human health globally; infecting a massive quantity of people around 136,046,262 (John Hopkins University); causing severe disease and associated long-term health sequelae; resulting in death and […]

Read Full Post »

Jason Sol Zielonka, MD, AFACC – Chief Scientific Officer

Posted in on March 18, 2020|

Jason Sol Zielonka, MD, AFACC – Chief Scientific Officer (CSO)   Roles @ LPBI:   A. Scientific in 2020-2021 CSO, Dr. Jason Zielonka, MD will be LPBI’s Lead Curator for Development of Medical Counter-measures for 2019-nCoV, CoVid19, Coronavirus on LPBI’s Coronavirus Portal It was launched on 3/14/2020 to cover various aspects of the viral infection pandemic Focusing […]

Read Full Post »

Transthyretin amyloid cardiomyopathy (ATTR-CM): U.S. FDA APPROVES VYNDAQEL® AND VYNDAMAX™ for this Rare and Fatal Disease 

Posted in Cardiomyopathy, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Pharmacotherapy of Cardiovascular Disease, Transthyretin amyloid cardiomyopathy (ATTR-CM) on October 29, 2019| Leave a Comment »

Transthyretin amyloid cardiomyopathy (ATTR-CM): U.S. FDA APPROVES VYNDAQEL® AND VYNDAMAX™ for this Rare and Fatal Disease Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 6/30/2021 CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis June 26, 2021 DOI: 10.1056/NEJMoa2107454 Abstract Background Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening disease characterized by progressive accumulation of misfolded […]

Read Full Post »

NEW GENRE Volume One: Cancer Biology and Genomics for Disease Diagnosis – Series C, Volume 1

Posted in on June 24, 2022|

View on Amazon.com http://www.amazon.com/dp/B0BQHFXKHH   Audio y Texto NEW GENRE Volume One: Cancer Biology and Genomics for Disease Diagnosis  https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-c-e-books-on-cancer-oncology/new-genre-volume-one-cancer-biology-and-genomics-for-disease-diagnosis-series-c-volume-1%ef%bf%bc/   Original Volume 1: Cancer Biology & Genomics for Disease Diagnosis.   On com since 8/11/2015 http://www.amazon.com/dp/B013RVYR2K   New Genre Volume One: Cancer Biology and Genomics for Disease Diagnosis This volume include graphical results of Medical Text Analysis with Machine Learning […]

Read Full Post »

Verily kicked off Project Baseline in April 2017, with a health study geared to gather health data from 10,000 people over four years – Partnership with Big Pharma on Clinical Trials announced on 5/21/2019

Posted in Health Care System by Country, HealthCare IT, Pharmaceutical R&D Informatics, Pharmacogenomics, United States on May 21, 2019| Leave a Comment »

Verily kicked off Project Baseline in April 2017, with a health study geared to gather health data from 10,000 people over four years – Partnership with Big Pharma on Clinical Trials announced on 5/21/2019   Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 5/22/2019 On Tuesday morning, Verily, Alphabet’s unit focused on life sciences, announced that it […]

Read Full Post »

« Prev - Next »